2,445
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Portrayals of 2v, 4v and 9vHPV vaccines on Chinese social media: a content analysis of hot posts on Sina Weibo

ORCID Icon, ORCID Icon, &
Pages 4433-4441 | Received 18 May 2021, Accepted 16 Aug 2021, Published online: 20 Sep 2021

Figures & data

Figure 1. Data collection and coding process.

1,731 raw data were obtained, and 1,164 data were valid. First, two coders independently coded 150 posts, and DivoMiner was used to code the remaining posts. Then, 192 (16.3%) of the 1,164 data were randomly extracted via DiVoMiner, and these were encoded manually again. The Krippendorf’s alpha exceeded 0.7, indicating that the machine coding had good reliability.
Figure 1. Data collection and coding process.

Table 1. Numbers of collected hot posts by various creators

Table 2. Numbers of collected hot posts by year

Figure 2. Number of collected hot posts per month and key time points of human papillomavirus vaccine news coverage in China.

(a) The approval of imported 2vHPV vaccine Cervarix® and 4vHPV vaccine Gardasil® did not receive significant coverage on Weibo. (b) More hot posts appeared when Cervarix® became available, and a peak of hot posts resulted from the start of Gardasil® vaccination. (c) No attention was drawn neither when imported 9vHPV vaccine was approved nor launched. (d) The approval and official launch of domestic 2vHPV vaccine Cecolin® were both widely discussed on Weibo. (e) The interference between SARS-CoV-2 vaccines and HPV vaccines led to the greatest number of hot Weibo posts on HPV vaccination.
Figure 2. Number of collected hot posts per month and key time points of human papillomavirus vaccine news coverage in China.

Table 3. Numbers of collected hot posts by region mentioned in the post content

Table 4. Trending themes in host posts included in the analysis (N = 1164)

Table 5. The descriptions of different types of HPV vaccines in hot Weibo posts

Supplemental material

Supplemental Material

Download MS Word (20.5 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.